Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Basophils are dispensable for the recovery of gross locomotion after spinal cord hemisection injury.
Participant recruitment into a randomised controlled trial of exercise therapy for people with multiple sclerosis.
Oligodendrocyte regeneration: its significance in myelin replacement and neuroprotection in multiple sclerosis.
ATP-Mediated Compositional Change in Peripheral Myelin Membranes: A Comparative Raman Spectroscopy and Time-Of-Flight Secondary Ion Mass Spectrometry Study.
Control of microglial neurotoxicity by the fractalkine receptor.
Axon growth inhibition by RhoA/ROCK in the central nervous system.
Long-term (up to 4.5 years) treatment with fingolimod in multiple sclerosis: results from the extension of the randomised TRANSFORMS study.
Younger age, female sex, and high number of awakenings and arousals predict fatigue in patients with sleep disorders: a retrospective polysomnographic observational study.
Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response.
Cost-Effectiveness Analysis of Peginterferon Beta-1a In The Treatment of Relapsing-Remitting Multiple Sclerosis In Ireland.
Retrospective Cohort Study of Gender Differential in Risk of Multiple Sclerosis in Kuwait.
Is Modulation of Oxidative Stress an Answer? The State of the Art of Redox Therapeutic Actions in Neurodegenerative Diseases.
The blood-brain barrier in systemic inflammation.
Deletion of Virus-specific T-cells Enhances Remyelination in a Model of Multiple Sclerosis.
Employment needs of people with multiple sclerosis: a review of current literature and application to occupational therapy practice.
Pharmacological Alternatives for the Treatment of Neurodegenerative Disorders: Wasp and Bee Venoms and Their Components as New Neuroactive Tools.
Spinster 2, a sphingosine-1-phosphate transporter, plays a critical role in inflammatory and autoimmune diseases.
Iron Oxide as an MRI Contrast Agent for Cell Tracking.
[Animal models for multiple sclerosis].
Challenges In Translating The Multiple Sclerosis International Quality of Life (Musiqol) Questionnaire In 57 Languages.
Self-esteem, social participation, and quality of life in patients with multiple sclerosis.
Glia-neuron interactions in neurological diseases: Testing non-cell autonomy in a dish.
[Intravenous immunoglobulin in treatment of autoimmune neurological diseases in children].
[Relevance of Magnet Resonance Tomography in the Diagnosis and Assessment of Course of Disease in Patients with Multiple Sclerosis].
The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration.
Pages
« first
‹ previous
…
702
703
704
705
706
707
708
709
710
…
next ›
last »